India Radiopharmaceuticals Market to 2032
Overview
The India Radiopharmaceuticals Market is expected to reach a 194.24 USD Billion by 2032 and is projected to grow at a CAGR of 6.37% from 2025 to 2032.
Revenue, 2024 (USD Billion)
137.23
Forecast, 2032 (USD Billion)
194.24
CAGR, 2024 - 2032
6.37%
Report Coverage
India
India Radiopharmaceuticals Market 2018-2032 USD Billion
India Radiopharmaceuticals Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 137.23 USD Billion
- Projected Market Size (2032): 194.24 USD Billion
- CAGR (2025-2032): 6.37%
Key Findings of India Radiopharmaceuticals Market
- The India Radiopharmaceuticals Market was valued at 194.24 USD Billion in 2024.
- The India Radiopharmaceuticals Market is likely to grow at a CAGR of 6.37% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Nuclear Reactors in By Source Segment accounted for the largest share of the market with a revenue of 81.60 USD Billion
- The fastest growing segment Hospitals in End User Segment grew Fastest with a CAGR of 7.10% during the forecast period from 2024 to 2032.
India Radiopharmaceuticals Market Scope
India Radiopharmaceuticals Market Segmentation & Scope
End User
- Others
- Ambulatory Surgical Centers
- Cancer Research Institutes
- Diagnostic Centers
- Hospitals
By Type
- Therapeutic Radiopharmaceuticals
- Diagnostic Radiopharmaceuticals
By Application
- Therapeutic
- Diagnostic
By Source
- Cyclotrons
- Nuclear Reactors
India Radiopharmaceuticals Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 137.23 USD Billion |
| Market Value in 2032 | 194.24 USD Billion |
| CAGR (2025-2032) | 6.37% |
| Historic Data | 2016-2023 |
| Market Segments Covered | End User,By Type,By Application,By Source |
Regional Insights:
-
Leading Market (2024-2032): India, leading in terms of revenue 137.23 USD Billion in 2024
- Key Country: India, leading in terms of revenue with value of 137.23 USD Billion in 2024.
Segments and Scope
-
India Radiopharmaceuticals Market to 2032, By End User
- Hospitals is the largest segment in India Radiopharmaceuticals Market to 2032 with a revenue of 52.11 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in India Radiopharmaceuticals Market to 2032 with a Growth rate of 7.10 % in forecast period 2025-2032.
-
India Radiopharmaceuticals Market to 2032, By By Type
- Diagnostic Radiopharmaceuticals is the largest segment in India Radiopharmaceuticals Market to 2032 with a revenue of 77.18 USD Billion in the year 2024.
- Diagnostic Radiopharmaceuticals is the Fastest growing segment in India Radiopharmaceuticals Market to 2032 with a Growth rate of 6.87 % in forecast period 2025-2032.
-
India Radiopharmaceuticals Market to 2032, By By Application
- Diagnostic is the largest segment in India Radiopharmaceuticals Market to 2032 with a revenue of 73.51 USD Billion in the year 2024.
- Diagnostic is the Fastest growing segment in India Radiopharmaceuticals Market to 2032 with a Growth rate of 6.90 % in forecast period 2025-2032.
-
India Radiopharmaceuticals Market to 2032, By By Source
- Nuclear Reactors is the largest segment in India Radiopharmaceuticals Market to 2032 with a revenue of 81.60 USD Billion in the year 2024.
- Nuclear Reactors is the Fastest growing segment in India Radiopharmaceuticals Market to 2032 with a Growth rate of 6.79 % in forecast period 2025-2032.
India Radiopharmaceuticals Market Company Share Analysis
| Company Name |
|
||
| Cardinal Health | |||
| Advanced Accelerator Applications, A Novartis Company | |||
| GE HealthCare | |||
| Lantheus | |||
| Curium and its affiliates | |||
India Radiopharmaceuticals Market Geographical Sales Distribution, 2018-2032 USD Billion
India Radiopharmaceuticals Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The India Radiopharmaceuticals Market is segmented based on Segmentation End User,By Type,By Application,By Source.
India Radiopharmaceuticals Market was valued at USD 137.23(Revenue in USD Billion) in 2021.
India Radiopharmaceuticals Market is projected to grow at a CAGR of 6.37% during the forecast period of 2024 to 2032.
The Nuclear Reactors segment is expected to dominate the India Radiopharmaceuticals Market, holding a largest market share of 81.60 USD Billion in 2024
India Radiopharmaceuticals Market Scope
India Radiopharmaceuticals Market Segmentation & Scope
End User
- Others
- Ambulatory Surgical Centers
- Cancer Research Institutes
- Diagnostic Centers
- Hospitals
By Type
- Therapeutic Radiopharmaceuticals
- Diagnostic Radiopharmaceuticals
By Application
- Therapeutic
- Diagnostic
By Source
- Cyclotrons
- Nuclear Reactors
Frequently Asked Questions
The India Radiopharmaceuticals Market is segmented based on Segmentation End User,By Type,By Application,By Source.
India Radiopharmaceuticals Market was valued at USD 137.23(Revenue in USD Billion) in 2021.
India Radiopharmaceuticals Market is projected to grow at a CAGR of 6.37% during the forecast period of 2024 to 2032.
The estimated market value of the India Radiopharmaceuticals Market for final year is USD 194.24 (USD Billion).
India Radiopharmaceuticals Market Company Profiling
Frequently Asked Questions
The India Radiopharmaceuticals Market is segmented based on Segmentation End User,By Type,By Application,By Source.
India Radiopharmaceuticals Market was valued at USD 137.23(Revenue in USD Billion) in 2021.
India Radiopharmaceuticals Market is projected to grow at a CAGR of 6.37% during the forecast period of 2024 to 2032.
The estimated market value of the India Radiopharmaceuticals Market for final year is USD 194.24 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.